Updates from The Motley Fool

Latest updates on Rexahn Pharmaceuticals from Fool.com.

Stock Performance

RNN vs. S&P 500 | 2 Year Performance
RNN 1-Day Stock Chart
RNN 5-Day Stock Chart
RNN 1-Month Stock Chart
RNN 3-Month Stock Chart
RNN 6-Month Stock Chart
RNN 1-Year Stock Chart
RNN 2-Year Stock Chart
RNN 5-Year Stock Chart
View Interactive RNN Charts
Sponsored by

Key Data Points

Primary metrics and data points about Rexahn Pharmaceuticals.
Current Price: $0.30
Prev Close: $0.30
Open: $0.31
Bid: $0.30
Ask: $0.40
Day's Range: $0.30 - $0.31
52wk Range: $0.26 - $0.77
Volume: 336,780
Avg Vol 434,086
Market Cap: $54.22M
P/E (ttm): -3.75
EPS (ttm): -$0.08
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Rexahn Pharmaceuticals.
CAPS Rating 2 out of 5
87 Outperform
14 Underperform
CAPS All Stars
7 Outperform
6 Underperform

How do you think Rexahn Pharmaceuticals will perform against the market?

You pick for Rexahn Pharmaceuticals is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

Business Summary

Industry, sector and description for Rexahn Pharmaceuticals.

Rexahn Pharmaceuticals Inc. is a clinical stage biopharmaceutical company developing and seeking to deliver novel cures for cancer and disorders of the central nervous system (CNS) to patients worldwide.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers